Executive Summary
The QQ1 2025 results for The Marquie Group Inc (TMGI) depict a financially stressed quarter with no reported revenue and a net loss of $204,944. The operating picture is dominated by a modest operating expense base of $60,640 combined with a sizable interest expense of $107,072, producing an EBITDA of −$97,779 and an operating loss of −$60,640. The quarter’s profitability metrics point to a finance-heavy structure rather than a cash generation story, underscored by a negative net income and a lack of reported revenue in the period.
Liquidity and balance-sheet health raise red flags. The company reports total current liabilities of $6.2355 million against total current assets of only $0.642 thousand, yielding an exceptionally weak current ratio (~0.0001) and a cash/quick ratio of 0, signaling material short-term liquidity risk. Net debt stands at $3.5376 million, while total stockholders’ equity sits at a nominal $11,492 with retained earnings deeply negative at −$15.068 million. Free cash flow for the quarter is negative at −$546, underscoring limited cash generation while financing activity offsets it modestly with a $546 inflow.
With no formal forward guidance disclosed in the filing and a large, announced long-term investment line of $6.2 million, the investment thesis rests on optionality: potential monetization or realization of value from non-core assets and any future revenue ramp from core radio/online platforms or the health/beauty product pipeline. Absent clear revenue visibility, investors face elevated downside risk and should focus on liquidity development, debt renegotiation prospects, and any incremental disclosures around revenue-generating activities or strategic asset reallocations.
Key Performance Indicators
QoQ: -375.04% | YoY:-158.04%
Key Insights
Revenue: Not disclosed for QQ1 2025 (reported as null). Cost of revenue: $93.00; Gross profit: −$93.00; Gross profit margin: N/A. Operating expenses: $60,640.00; Interest expense: $107,072.00; Depreciation & amortization: $93.00; EBITDA: −$97,779.00. Operating income: −$60,640.00; Total other income/expenses: −$144,304.00; Income before tax: −$204,944.00; Net income: −$204,944.00; Weighted average shares outstanding: 3,325,531,102.
Balance sheet highlights: Total assets: $6,247...
Financial Highlights
Revenue: Not disclosed for QQ1 2025 (reported as null). Cost of revenue: $93.00; Gross profit: −$93.00; Gross profit margin: N/A. Operating expenses: $60,640.00; Interest expense: $107,072.00; Depreciation & amortization: $93.00; EBITDA: −$97,779.00. Operating income: −$60,640.00; Total other income/expenses: −$144,304.00; Income before tax: −$204,944.00; Net income: −$204,944.00; Weighted average shares outstanding: 3,325,531,102.
Balance sheet highlights: Total assets: $6,247,044; Total current assets: $642; Inventory: $642; Intangible assets: $11,165; Long-term investments: $6,200,000; Other non-current assets: $35,879; Total liabilities: $6,235,552 (Current liabilities: $6,235,552; Short-term debt: $3,537,583; Other current liabilities: $2,620,895); Total stockholders’ equity: $11,492 (Retained earnings: −$15,068,430; Other equity: $14,747,367). Liquidity ratios: Current ratio 0.0001; Quick ratio 0; Debt/Equity 307.83; Debt/Total capitalization 0.997; Net debt $3,537,583; Cash flow (operating): −$546; Free cash flow: −$546.
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Gross Profit |
-93.00 |
59.57% |
-107.83% |
| Operating Income |
-60.64K |
21.80% |
65.75% |
| Net Income |
-204.94K |
-158.04% |
-375.04% |
Key Financial Ratios
operatingCashFlowPerShare
$-0
Management Commentary
No QQ1 2025 earnings call transcript is provided in the data set. As a result, there are no management quotes or themes to quote verbatim. The analytical output below notes the absence of management commentary from the transcript.
Forward Guidance
No explicit forward guidance is disclosed in the QQ1 2025 filing. Given the liquidity stress, high short-term leverage and missing revenue in the quarter, near-term targets are not clearly defined. The execution risk is high absent a revenue ramp or a credible plan to de-lever and stabilize operating cash flow. Investors should monitor: (1) any revenue disclosures or recognition updates for the radio/online network and health/beauty product pipeline, (2) debt refinancing terms or potential balance-sheet restructurings, (3) capital expenditure plans and any monetization or disposition of non-core long-term investments, and (4) quarterly progress on working capital optimization and cost control measures.